UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort.
- Cescon A, Cooper C, Chan K, Palmer A, Klein M, Machouf N, Loutfy M, Raboud J, Rachlis A, Ding E, Lima V, Montaner J, Rourke S, Smieja M, Tsoukas C, Hogg R; for the CANOC Collaboration.SourceBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada The Ottawa Hospital Division of Infectious Diseases, University of Ottawa, Ottawa, Canada The Montreal Chest Institute, McGill University Health Centre, Montreal, Canada Faculty of Medicine, McGill University, Montreal, Canada Clinique Medicale l'Actuel, Montreal, Canada Maple Leaf Medical Clinic, Toronto, Canada Faculty of Medicine, University of Toronto, Toronto, Canada Dalla Lana School of Public Health, University of Toronto, Toronto, Canada Division of Infectious Diseases, University Health Network, Toronto, Canada Sunnybrook Health Sciences Centre, Toronto, Canada Division of AIDS, Department of Medicine, University of British Columbia, Vancouver, Canada The Ontario HIV Treatment Network, Toronto, Canada Faculty of Health Sciences, McMaster University, Hamilton, Canada.
- HIV medicine.HIV Med.2011 Jul;12(6):352-360. doi: 10.1111/j.1468-1293.2010.00890.x. Epub 2010 Nov 8.
- OBJECTIVE: The aim of the study was to evaluate time to virological suppression in a cohort of individuals who started highly active antiretroviral therapy (HAART), and to explore the factors associated with suppression.METHODS: Eligible participants were HIV-positive individuals from a multi-site C
- PMID 21059167
- Coadministration With Lopinavir and Ritonavir Decreases Exposure to BILR 355, a Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy Volunteers.
- Huang F, Scholl P, Huang DB, Macgregor TR, Vinisko R, Castles MA, Berger F, Robinson P.SourceClinical Pharmacokinetics & Pharmacodynamics, Boehringer Ingelheim Pharmaceuticals, Inc, 900 Ridgebury Rd, Ridgefield, CT 06877-0368; email: fenglei.huang@boehringer-ingelheim.com.
- Journal of clinical pharmacology.J Clin Pharmacol.2011 Jul;51(7):1061-70. Epub 2010 Aug 12.
- The objective of this investigation was to evaluate the pharmacokinetic interaction of lopinavir/ritonavir (LPV/r) with BILR 355. In group A, 26 healthy participants were administered LPV/r (400mg/100mg) twice daily for 14 days, followed by coadministration of BILR 355, 150 mg twice daily for an add
- PMID 20705951
Japanese Journal
- Nonnucleoside HIV-1 Reverse-Transcriptase Inhibitors, Part 5. : Synthesis and Anti-HIV-1 Activity of Novel 6-Naphthylthio HEPT Analogues
- SUN Guang Fu,CHEN Xu Xiang,CHEN Fen Er,WANG Yue Ping,CLERCQ Erik De,BALZARINI Jan,PANNECOUQUE Christophe
- Chemical & pharmaceutical bulletin 53(8), 886-892, 2005-08-01
- As part of a series of studies to discover new HIV reverse-transcriptase inhibitors, various novel 6α- and 6β-naphthylthio 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio) thymine (HEPT) derivatives were sy …
- NAID 10016655563
- Conventional HPLC Method Used for Simultaneous Determination of the Seven HIV Protease Inhibitors and Nonnucleoside Reverse Transcription Inhibitor Efavirenz in Human Plasma(Analytical Biochemistry)
- TAKAHASHI Masaaki,YOSHIDA Masao,OKI Tsuyoshi,OKUMURA Naoya,SUZUKI Tatsuo,KANEDA Tsuguhiro
- Biological & pharmaceutical bulletin 28(7), 1286-1290, 2005-07-01
- … We developed a simple HPLC method for the simultaneous quantitative determination of seven HIV protease inhibitors: amprenavir (APV), atazanavir (ATV), indinavir (IDV), lopinavir (LPV), nelfinavir (NFV), ritonavir (RTV), saquinavir (SQV), and a nonnucleoside reverse transcription inhibitor, efavirenz (EFV). …
- NAID 10016665684
Related Links
- Non-nucleoside reverse-transcriptase inhibitors (NNRTIs) are the third class of antiretroviral drugs that were developed. In all cases, patents remain in force until beyond 2007. This class of drugs was first described at the Rega ...
Related Pictures
★リンクテーブル★
[★]
非ヌクレオシド系逆転写酵素阻害薬 NNRTI
[★]
非核酸系逆転写酵素阻害薬